189 Publications (Page 3 of 8)
2016
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer.
Robarge, Jason DDesta, ZereunesayNguyen, Anne TLi, LangHertz, DanielRae, James MHayes, Daniel FStorniolo, Anna MStearns, VeredFlockhart, David ASkaar, Todd C and Henry, N Lynn
Breast cancer research and treatment, December 9, 2016. | Journal Article
 
ESR1 and PGR Polymorphisms Affect Estrogen and Progesterone Receptor Expression in Breast Tumors.
Hertz, Daniel LHertz, D.L.Hertz, Daniel LHertz, Daniel LHenry, N LynnHenry, N LynnHenry, N LynnHenry, N.L.Kidwell, Kelley MKidwell, K.M.Kidwell, Kelley MKidwell, Kelley MThomas, DafyddThomas, DafyddThomas, D.Thomas, DafyddGoddard, A.Goddard, AudreyGoddard, AudreyGoddard, AudreyAzzouz, FaouziAzzouz, FaouziAzzouz, F.Azzouz, FaouziSpeth, KellySpeth, KellySpeth, KellySpeth, K.Li, LangLi, L.Li, LangLi, LangBanerjee, MousumiBanerjee, MousumiBanerjee, MousumiBanerjee, M.Thibert, J.N.Thibert, Jacklyn NThibert, Jacklyn NThibert, Jacklyn NKleer, Celina GKleer, C.G.Kleer, Celina GKleer, Celina GStearns, VeredStearns, VeredStearns, V.Stearns, VeredHayes, D.F.Hayes, Daniel FHayes, Daniel FHayes, Daniel FSkaar, Todd CSkaar, T.C.Skaar, Todd CSkaar, ToddRae, James MRae, James MRae, J.M. and Rae, James M
Physiological genomics, pp. physiolgenomics.00065.2016, August 19, 2016. | Journal Article
 
Identification of rifampin-regulated functional modules and related microRNAs in human hepatocytes based on the protein interaction network.
Li, JinWang, YingWang, LeiDai, XuefengCong, WangFeng, WeixingXu, ChengzhenDeng, YulinWang, YueSkaar, Todd CLiang, Hong and Liu, Yunlong
BMC genomics, vol. 17, pp. 517. | Journal Article
 
Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.
Eadon, M TDesta, ZLevy, K DDecker, B SPierson, R CPratt, V MCallaghan, J TRosenman, M BCarpenter, J SHolmes, A MMcDonald, C ABenson, E APatil, A SVuppalanchi, RGufford, B TDave, NRobarge, J DHyder, M AHaas, D MKreutz, R PDexter, P RSkaar, T C and Flockhart, D A
Clinical pharmacology and therapeutics, vol. 100, (no. 1), pp. 63-66, July 2016. | Journal Article
 
Inhibition of CYP2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy Volunteers.
Desta, ZeruesenayMetzger, Ingrid FThong, NancyLu, Jessica B LCallaghan, John TSkaar, Todd CFlockhart, David A and Galinsky, Raymond E
Antimicrobial agents and chemotherapy, September 6, 2016. | Journal Article
 
Inhibition of Cytochrome P450 2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy Volunteers
Desta, ZeruesenayDesta, ZeruesenayDesta, ZeruesenayMetzger, Ingrid FMetzger, Ingrid FMetzger, Ingrid FThong, NancyThong, NancyThong, NancyLu, Jessica B LLu, Jessica B LLu, Jessica B LCallaghan, John TCallaghan, John TCallaghan, John TSkaar, Todd CSkaar, Todd CSkaar, Todd CFlockhart, David AFlockhart, David AFlockhart, David AGalinsky, Raymond EGalinsky, Raymond E and Galinsky, Raymond E
Antimicrobial agents and chemotherapy, vol. 60, (no. 11), pp. 6822, 2016-11-00. | Journal Article
 
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.
Kadakia, Kunal CKadakia, K.C.Kadakia, Kunal CSnyder, Claire FSnyder, C.F.Snyder, Claire FKidwell, K.M.Kidwell, Kelley MKidwell, Kelley MSeewald, Nicholas JSeewald, Nicholas JSeewald, N.J.Flockhart, D.A.Flockhart, David AFlockhart, David ASkaar, T.C.Skaar, Todd CSkaar, Todd CDesta, ZereunesayDesta, Z.Desta, ZereunesayRae, James MRae, J.M.Rae, James MOtte, Julie LOtte, J.L.Otte, Julie LCarpenter, Janet SCarpenter, J.S.Carpenter, Janet SStorniolo, Anna MStorniolo, A.M.Storniolo, Anna MHayes, Daniel FHayes, D.F.Hayes, Daniel FStearns, VeredStearns, VeredStearns, V.Henry, N. LynnHenry, N Lynn and Lynn Henry, N.
The oncologist, vol. 21, (no. 5), pp. 539-546, May 2016. | Journal Article
 
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
Hertz, D LKidwell, K MSeewald, N JGersch, C LDesta, ZFlockhart, D AStorniolo, A-MStearns, VSkaar, T CHayes, D FHenry, N L and Rae, J M
The pharmacogenomics journal, August 23, 2016. | Journal Article
 
Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteers.
Cho, Doo-YeounShen, Joan H QLemler, Suzanne MSkaar, Todd CLi, LangBlievernicht, JuliaZanger, Ulrich MKim, Kwon-BokShin, Jae-GookFlockhart, David A and Desta, Zeruesenay
Drug metabolism and pharmacokinetics, vol. 31, (no. 2), pp. 107-116, April 2016. | Journal Article
 
Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes.
Benson, Eric ABenson, Eric ABenson, Eric A.Eadon, Michael TEadon, Michael T.Eadon, Michael TDesta, ZeruesenayDesta, ZeruesenayDesta, ZeruesenayLiu, YunlongLiu, YunlongLiu, YunlongLin, HaiLin, HaiLin, HaiBurgess, Kimberly SBurgess, Kimberly SBurgess, Kimberly S.Segar, Matthew WSegar, Matthew WSegar, Matthew W.Gaedigk, AndreaGaedigk, AndreaGaedigk, AndreaSkaar, Todd C.Skaar, Todd C and Skaar, Todd C
Frontiers in pharmacology, vol. 7, pp. 111, 2016. | Journal Article
 
Sleep disorders in breast cancer survivors
Otte, JulieOtte, JulieOtte, J.L.Davis, LorieDavis, LorieDavis, L.Carpenter, JanetCarpenter, J.S.Carpenter, JanetKrier, C.Krier, ConnieKrier, ConnieSkaar, T.C.Skaar, ToddSkaar, ToddRand, KevinRand, KevinRand, K.L.Weaver, MichaelWeaver, MichaelWeaver, M.Landis, C.Landis, CarolLandis, CarolChernyak, YelenaChernyak, YelenaChernyak, Y.Manchanda, ShaliniManchanda, Shalini and Manchanda, S.
Supportive Care in Cancer, vol. 24, (no. 10), pp. 4197-4205, Oct 2016. | Journal Article
 
Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.
Lv, WeiLiu, JinzhongSkaar, Todd CO'Neill, ElizavetaYu, GeFlockhart, David A and Cushman, Mark
Journal of medicinal chemistry, vol. 59, (no. 1), pp. 157-170, January 14, 2016. | Journal Article
 
TOLERABILITY OF ACETYLCHOLINESTERASE INHIBITORS BY CYP2D6 ACTIVITY
Campbell, NollCampbell, NollCampbell, NollPerkins, TonyPerkins, TonyPerkins, TonySkaar, ToddSkaar, ToddSkaar, ToddBoustani, MalazBoustani, Malaz and Boustani, Malaz
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol. 12, (no. 7), pp. P427, 2016. | Journal Article
2015
Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver.
Burgess, K SBurgess, KsPhilips, SPhilips, SBenson, E ABenson, EADesta, ZDesta, ZGaedigk, AGaedigk, AGaedigk, RGaedigk, RSegar, M WSegar, MWLiu, YLiu, YSkaar, TC and Skaar, T C
Clinical pharmacology and therapeutics, vol. 98, (no. 2), pp. 205-215, August 2015. | Journal Article
 
AMPD1 polymorphism and response to regadenoson.
Saab, RayanSaab, RayanZouk, Aline NZouk, Aline NMastouri, RonaldMastouri, RonaldSkaar, Todd CSkaar, Todd CPhilips, SantoshPhilips, SantoshKreutz, Rolf P and Kreutz, Rolf P
Pharmacogenomics, vol. 16, (no. 16), pp. 1807-1815, November 2015. | Journal Article
 
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover.
Oesterreich, SteffiOesterreich, SteffiOesterreich, SteffiOesterreich, SteffiHenry, NHenry, N LHenry, N LynnHenry, NKidwell, KelleyKidwell, Kelley MKidwell, Kelley MKidwell, KelleyVan Poznak, Catherine HVan Poznak, CatherineVan Poznak, CatherineVan Poznak, Catherine HSkaar, ToddSkaar, ToddSkaar, Todd CSkaar, Todd CDantzer, JessicaDantzer, JessicaDantzer, JessicaDantzer, JessicaLi, LangLi, LangLi, LangLi, LangHangartner, ThomasHangartner, ThomasHangartner, Thomas NHangartner, Thomas NPeacock, MunroPeacock, MunroPeacock, MunroPeacock, MunroNguyen, AnneNguyen, AnneNguyen, Anne TNguyen, Anne TRae, JamesRae, JamesRae, James MRae, James MDesta, ZeruesenayDesta, ZeruesenayDesta, ZeruesenayDesta, ZeruesenayPhilips, SantoshPhilips, SantoshPhilips, SantoshPhilips, SantoshStorniolo, Anna MStorniolo, AnnaStorniolo, Anna MStorniolo, AnnaStearns, VeredStearns, VeredStearns, VeredStearns, VeredHayes, Daniel FHayes, DanielHayes, DanielHayes, Daniel FFlockhart, David AFlockhart, DavidFlockhart, David and Flockhart, David A
Breast cancer research and treatment, vol. 154, (no. 2), pp. 263-273, November 2015. | Journal Article
 
A translational bioinformatic approach in identifying and validating an interaction between Vitamin A and CYP19A1.
Philips, SantoshPhilips, SantoshPhilips, SantoshZhou, JingZhou, JingZhou, JingLi, ZhigaoLi, ZhigaoLi, ZhigaoSkaar, Todd CSkaar, Todd CSkaar, Todd CLi, LangLi, Lang and Li, Lang
BMC genomics, vol. 16 Suppl 7, pp. S17, 2015. | Journal Article
 
A two-week regimen of high-dose integrase inhibitors does not cause nephrotoxicity in mice.
Eadon, Michael TEadon, Michael TZhang, HongjiZhang, HongjiSkaar, Todd CSkaar, Todd CHato, TakashiHato, TakashiDagher, Pierre CDagher, Pierre CGupta, Samir KGupta, Samir KDesta, Zeruesenay and Desta, Zeruesenay
Antiviral chemistry & chemotherapy, vol. 24, (no. 2), pp. 72-76, April 2015. | Journal Article
 
Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study.
Benson, Eric ABenson, Eric ASkaar, Todd CSkaar, Todd CLiu, YunlongLiu, YunlongNephew, Kenneth PNephew, Kenneth PMatei, Daniela and Matei, Daniela
PloS one, vol. 10, (no. 10), pp. e0141279, 2015. | Journal Article
 
Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy.
Campbell, Noll LCampbell, Noll LCampbell, Noll LSkaar, Todd CSkaar, Todd CSkaar, Todd CPerkins, Anthony JPerkins, Anthony JPerkins, Anthony JGao, SujuanGao, SujuanGao, SujuanLi, LangLi, LangLi, LangKhan, Babar AKhan, Babar AKhan, Babar ABoustani, Malaz ABoustani, Malaz A and Boustani, Malaz A
Clinical interventions in aging, vol. 10, pp. 269-275, 2015. | Journal Article
 
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
Hicks, J.K.Hicks, J KBishop, J.R.Bishop, J RSangkuhl, K.Sangkuhl, KMuller, D.J.Müller, D JJi, Y.Ji, YLeckband, S GLeckband, S.G.Leeder, J SLeeder, J.S.Graham, R LGraham, R.L.Chiulli, D LChiulli, D.L.LLerena, A.LLerena, ASkaar, T CSkaar, T.C.Scott, S.A.Scott, S AStingl, J CStingl, J.C.Klein, T.E.Klein, T ECaudle, K ECaudle, K.E.Gaedigk, A. and Gaedigk, A
Clinical pharmacology and therapeutics, vol. 98, (no. 2), pp. 127-134, August 2015. | Journal Article
 
Comparison of genotyping performance in DNA extracted from matched FFPE tumor, FFPE lymph node, and whole blood for pharmacogenetic analyses
Hertz, Daniel LouisKidwell, Kelley MThibert, Jacklyn NGersch, Christina LRegan, Meredith MSkaar, Todd CHenry, Norah LynnHayes, DanielVan Poznak, Catherine and Rae, James M
Journal of Clinical Oncology, vol. 33, (no. 15_suppl), pp. 1528, 2015-05-20. | Journal Article
 
Considerations for the Utility of the CPIC Guideline for CYP2D6 Genotype and Codeine Therapy
Crews, KristineCaudle, KellyDunnenberger, HenrySadhasivam, Senthilkumar and Skaar, Todd
(pp. 775-776). May 2015
 
Considerations for the Utility of the CPIC Guideline for CYP2D6 Genotype and Codeine Therapy.
Crews, Kristine RCrews, Kristine RCaudle, Kelly ECaudle, Kelly EDunnenberger, Henry MDunnenberger, Henry MSadhasivam, SenthilkumarSadhasivam, SenthilkumarSkaar, Todd C and Skaar, Todd C
Clinical chemistry, vol. 61, (no. 5), pp. 775-776, May 2015. | Journal Article
 
Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.
Numanagić, IbrahimMalikić, SalemPratt, Victoria MSkaar, Todd CFlockhart, David A and Sahinalp, S Cenk
Bioinformatics (Oxford, England), vol. 31, (no. 12), pp. i27-i34, June 15, 2015. | Journal Article